|Table of Contents|

Association analysis of non-high-density lipoprotein-cholesterol and TC/HDL-C ratio with cancer risk

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 17
Page:
3289-3295
Research Field:
Publishing date:

Info

Title:
Association analysis of non-high-density lipoprotein-cholesterol and TC/HDL-C ratio with cancer risk
Author(s):
XIE Yijing1JIANG Yonggen2WU Yiling2SU Xuyan2ZHU Dongliang1WANG Jingru1GAO Peipei3YUAN Huangbo3ZHAO Qi1XU Kelin1ZHANG Tiejun145MAN Qiuhong6CHEN Xingdong457ZHAO Genming1JIANG Yanfeng35SUO Chen158
Keywords:
lipid-related indexesnon-HDL-CTC/HDL-Ccancer risk
PACS:
R730.1
DOI:
10.3969/j.issn.1672-4992.2023.17.027
Abstract:
Objective:Exploring the association between levels of non-HDL-C and TC/HDL-C ratio and cancer risk to assess the values in cancer prevention.Methods: The study was conducted on the general population cohort between April 2016 and November 2017 in several communities of Songjiang District.Permanent residents aged 20~74 years were recruited and they completed the questionnaires,physical examinations,and laboratory tests(blood and urine).Cox proportional hazard models and multivariable restricted cubic spline models were both used to assess the association and dose-response relationship of non-HDL-C and TC/HDL-C with cancer risk.Results:A total of 33 414 participants were involved,with a median follow-up year of 4.88,and 911 were newly diagnosed with cancer.There was an inverse association between non-HDL-C levels and cancer risk,and a 1-SD increment of non-HDL-C decreased cancer risk by 9%.Individuals with TC/HDL-C at 2.03~2.97 had an increased risk of cancer.Individuals with high non-HDL-C levels had a lower risk of developing cancer than those with low non-HDL-C levels was shown in males and the population without diabetes[HR(95%CI)=0.74(0.56,0.99),HR(95%CI)=0.79(0.64,0.98)].Conclusion:non-HDL-C levels were associated with cancer risk,and it may be a potential modifiable risk factor of cancer.

References:

[1]CAO W,CHEN HD,YU YW,et al.Changing profiles of cancer burden worldwide and in China:a secondary analysis of the global cancer statistics 2020[J].Chinese Medical Journal,2021,134(7):783-791.
[2]STROHMAIER S,EDLINGER M,MANJER J,et al.Total serum cholesterol and cancer incidence in the metabolic syndrome and cancer project(Me-Can)[J].PLoS One,2013,8(1):e54242.
[3]HIS M,ZELEK L,DESCHASAUX M,et al.Prospective associations between serum biomarkers of lipid metabolism and overall,breast and prostate cancer risk[J].European Journal of Epidemiology,2014,29(2):119-132.
[4]BORGQUIST S,BUTT T,ALMGREN P,et al.Apolipoproteins,lipids and risk of cancer[J].International Journal of Cancer,2016,138(11):2648-2656.
[5]胡北平,汪天培,朱猛,等.血脂水平和遗传因素与男性肿瘤发病风险关联[J].中华疾病控制杂志,2021,25(09):1003-1007.HU BP,WANG TP,ZHU M,et al.Association of blood lipid and genetic factor with cancer risk in men[J].Chinese Journal of Disease Control and Prevention,2021,25(09):1003-1007.
[6]CALLING S,JOHANSSON SE,WOLFF M,et al.Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease:a 17-year follow-up study of women in southern Sweden[J].BMC Cardiovascular Disorders,2021,21(1):163.
[7]GUAN XM,WU SL,YANG XL,et al.Association of total cholesterol,low-density lipoprotein cholesterol,and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population[J].International Journal of Cancer,2018,142(6):1209-1217.
[8]TANG M,ZHAO Q,YI K,et al.Association between four nontraditional lipids and ischemic stroke:a cohort study in Shanghai,China[J].Lipids in Health and Disease,2022,21(1):72.
[9]于洋杰,谢坤,高秀芳,等.非高密度脂蛋白胆固醇可以替代低密度脂蛋白胆固醇吗[J].心血管病学进展,2021,42(01):12-16.YU YJ,XIE K,GAO XF,et al.Can LDL-Cbe replaced by non-HDL-C[J].Advances in Cardiovascular Diseases,2021,42(01):12-16.
[10]牛松涛,王安心,吴建维,等.非高密度脂蛋白胆固醇水平与周围动脉疾病的相关性研究[J].中国卒中杂志,2021,16(6):590-595.NIU ST,WANG AX,WU JW,et al.Association between non-high-density lipoprotein cholesterol level and peripheral artery disease[J].Chinese Journal of Stroke,2021,16(6):590-595.
[11]RIDKER PM,RIFAI N,COOK NR,et al.Non-HDL cholesterol,apolipoproteins A-I and B100,standard lipid measures,lipid ratios,and CRP as risk factors for cardiovascular disease in women[J].JAMA,2005,294(3):326-333.
[12]李莹,陈志红,周北凡,等.我国中年人群血清TC/HDL-C比值与缺血性和出血性脑卒中发病危险性[J].中华神经科杂志,2005,38(05):305-308.LI Y,CHEN ZH,ZHOU BF,et al.Serum TC/HDL-C ratio and the risk of ischemic and hemorrhagic stroke incidence in middle aged Chinese population[J].Chinese Journal of Neurology,2005,38(05):305-308.
[13]WADSTRM BN,WULFF AB,PEDERSEN KM,et al.Elevated remnant cholesterol increases the risk of peripheral artery disease,myocardial infarction,and ischaemic stroke:a cohort-based study[J].European Heart Journal,2022,43(34):3258-3269.
[14]HOLMES MV,MILLWOOD IY,KARTSONAKI C,et al.Lipids,lipoproteins,and metabolites and risk of myocardial infarction and stroke[J].Journal of the American College of Cardiology,2018,71(6):620-632.
[15]KATZKE VA,SOOKTHAI D,JOHNSON T,et al.Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort[J].BMC Medicine,2017,15(1):218.
[16]CHOWDHURY FA,ISLAM MF,PROVA MT,et al.Association of hyperlipidemia with breast cancer in Bangladeshi women[J].Lipids in Health and Disease,2021,20(1):52.
[17]赵琦,姜永根,王娜,等.上海市郊区自然人群队列和生物样本库建设[J].中华流行病学杂志,2023,44(1):28-33.ZHAO Q,JIANG YG,WANG N,et al.Establishment of Shanghai suburban adult cohort and biobank[J].Chinese Journal of Epidemiology,2023,44(1):28-33
[18] ZHAO Q,CHEN B,WANG RP,et al.Cohort profile:protocol and baseline survey for the Shanghai Suburban Adult Cohort and Biobank(SSACB) study[J].BMJ Open,2020,10(7):e035430.
[19]朱之鑫,朱向东,卢春恒.《中国2000年全国人口普查资料》[M].北京:中国统计出版社,2002:35.ZHU ZX,ZHU XD,LU CH.Tabulation on the 2000 population census of the Peoples Republic of China[M].Beijing:China Statistic Press,2002:35.
[20]MARTIN LJ,MELNICHOUK O,HUSZTI E,et al.Serum lipids,lipoproteins,and risk of breast cancer:a nested case-control study using multiple time points[J].Journal of the National Cancer Institute,2015,107(5):djv032.
[21]QIU X,LI Y,MA M,et al.Novel application of the traditional lipid ratios as strong risk predictors of nonsmall-cell lung cancer risk in a Chinese population[J].Medicine,2022,101(35):e30230.
[22]AGONGO G,RAAL F,NONTERAH EA,et al.Non-HDL-C and LDL-C/HDL-C are associated with self-reported cardiovascular disease in a rural West African population:Analysis of an array of lipid metrics in an AWI-Gen sub-study[J].PLoS One,2022,17(12):e0278375.
[23]SHOJI T,MASAKANE I,WATANABE Y,et al.Elevated non-high-density lipoprotein cholesterol(non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients[J].Clinical Journal of the American Society of Nephrology,2011,6(5):1112-1120.
[24]李超,白明,彭瑜,等.非高密度脂蛋白胆固醇与冠状动脉病变严重程度的相关性[J].中国动脉硬化杂志,2019,27(4):344-348.LI C,BAI M,PENG Y,et al.Correlation of non-high density lipoprotein cholesterol levels and artery atherosclerosis severity[J].Chinese Journal of Arteriosclerosis,2019,27(4):344-348.
[25]刘洋,郭阳.非高密度脂蛋白胆固醇(non-HDL-C)与颅内外动脉硬化狭窄的关系[J].中风与神经疾病杂志,2016,33(10):890-893.LIU Y,GUO Y.Association between non-high-density-lipoprotein-cholesterol levels and intracranial and extracranial atherosclerosis[J].Journal of Apoplexy and Nervous Diseases,2016,33(10):890-893.
[26]PATEL KK,KASHFI K.Lipoproteins and cancer:The role of HDL-C,LDL-C,and cholesterol-lowering drugs[J].Biochemical Pharmacology,2022,196:114654.
[27]KING RJ,SINGH PK,MEHLA K.The cholesterol pathway:impact on immunity and cancer[J].Trends in Immunology,2022,43(1):78-92.
[28]KUZU OF,NOORY MA,ROBERTSON GP.The role of cholesterol in cancer[J].Cancer Research,2016,76(8):2063-2070.
[29]MURAI T,MARUYAMA Y,MIO K,et al.Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration[J].The Journal of Biological Chemistry,2011,286(3):1999-2007.
[30]NAGO N,ISHIKAWA S,GOTO T,et al.Low cholesterol is associated with mortality from stroke,heart disease,and cancer:the Jichi Medical School cohort study[J].Journal of Epidemiology,2011,21(1):67-74.
[31]BLUM MR,POPAT RA,NAGY A,et al.Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome[J].Journal of Endocrinological Investigation,2021,44(10):2123-2130.
[32]CHIEFARI E,MIRABELLI M,LA VIGNERA S,et al.Insulin resistance and cancer:in search for a causal link[J].International Journal of Molecular Sciences,2021,22(20):11137.
[33]LYU Z,LI N,WANG G,et al.Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males:A prospective cohort study[J].International Journal of Cancer,2019,144(12):2972-2984.

Memo

Memo:
国家重点研发计划项目(编号:2019YFC1315804,2022YFC3400700);国家重点研发计划“精准医学研究”重点专项(编号:2017YFC0907000);National Natural Science Foundation of China(No.82073637);国家自然科学基金项目(编号:82073637);上海市自然科学基金(编号:20ZR1405600);江苏省泰州市科技支撑计划(编号:TS202224);上海市第四人民医院学科助推计划重点项目(编号:SY-XKZT-2020-1002)
Last Update: